Impact of neoadjuvant multimodal therapy in the setting of locally advanced hepatocellular carcinoma  

作　　者：Daniele Ferraro Federica Falaschi Luca Nazzaro Giovanni Vennarecci 

机构地区：[1]Hepato-biliary and Liver Transplant Centre,Department of General Surgery and Woman’s Health,AORN Antonio Cardarelli,Naples 80131,Italy

出　　处：《World Journal of Gastroenterology》2024年第28期3452-3455,共4页世界胃肠病学杂志（英文版）

摘　　要：Immunotherapy and the implementation of more aggressive treatment schemes for locally advanced hepatocellular carcinomas have expanded the boundaries of curative options.Because of these advancements,patients who were once considered beyond the aim of a cure are now eligible for liver transplantation and resection.

关 键 词：Hepatocellular carcinoma IMMUNOTHERAPY RADIOEMBOLIZATION CHEMOEMBOLIZATION Liver transplantation Liver resection 

分 类 号：R735.7[医药卫生—肿瘤]